Learn how our renal genetic testing was developed by a team of experts and is among the most comprehensive diagnostic testing available.
Mayo Clinic Labs @Work: Katie Perry - Insights
Katie Perry’s work as a supervisor for the Mayo Lab Inquiry call center helps ensure that clients get the information they need, when they need it, and smooths the way for tests to be completed without delay.
Medication-targeted testing - Insights
Learn more about how medication targeted testing at Mayo Clinic Laboratories can assist in treatment optimization for medication with established pharmacogenomic associations.
Fergus Couch, Ph.D., Awarded Breast Cancer Research Foundation Grant - Insights
The Breast Cancer Research Foundation has awarded a research grant to Fergus Couch, Ph.D., for his research proposal, “Inherited Genetic Risk Factors for Breast Cancer.” Dr. Couch will receive $250,000 to use toward his research efforts...
CPT Codes and LOINC Update: March 2020 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of March 2020.
New Tests Launched in August - Insights
In August 2017, Mayo Medical Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Nurturing Our Laboratories - Insights
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Alex Klobassa, assistant supervisor for transfusion medicine in the Department of Laboratory Medicine and Pathology at Mayo Clinic to discuss nurturing our...
How to Create Strong Professional Presentations - Insights
In this episode of “Lab Medicine Rounds,” guest host, Ann Moyer, M.D., Ph.D., speaks with Justin Kreuter, M.D., transfusion medicine pathologist and assistant professor of pathology and laboratory medicine at Mayo Clinic about the...
Maximizing Impact Through Admin-Lab Collaboration - Insights
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with operations administrator Mark Brown to discuss the significance of collaborating with administrators.
A team of researchers has confirmed that neutralizing monoclonal antibody (nMAb) therapies are associated with reduced risk of adverse outcomes of COVID-19 in high-risk populations. The cohort study, published in JAMA, included more than...